Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study, Therapeutic Advances in Medical Oncology, January 2020, SAGE Publications,
DOI: 10.1177/1758835920922022.
You can read the full text:

Read

Contributors

The following have contributed to this page